RCPA advises against SARS-CoV-2 serology for the diagnosis of acute COVID-19 infection
31 May, 2022

In a new position statement released today, the Royal College of Pathologists of Australasia (RCPA) advises that serology testing has limited use in the diagnosis of COVID-19. If serology testing must be performed, the RCPA recommends that only laboratory-based assays are used due to their higher sensitivity and specificity and the current lack of a clinical or public health need for rapid point-of-care SARS-CoV-2 serology testing.

Go Back

Page last updated:

Copyright © 2022 RCPA. All rights reserved.